Credit Suisse Group started coverage on shares of HCA Holdings, Inc. (NYSE:HCA) in a report issued on Thursday, November 2nd. The firm issued an outperform rating and a $95.00 price target on the stock.
Other research analysts also recently issued research reports about the stock. Robert W. Baird restated a buy rating on shares of HCA Holdings in a research report on Thursday, September 28th. Zacks Investment Research downgraded shares of HCA Holdings from a buy rating to a hold rating in a research report on Friday, July 14th. Piper Jaffray Companies restated a buy rating and issued a $92.00 price target on shares of HCA Holdings in a research report on Wednesday, October 4th. Cantor Fitzgerald restated a buy rating and issued a $95.00 price target on shares of HCA Holdings in a research report on Friday, October 13th. Finally, Raymond James Financial, Inc. downgraded shares of HCA Holdings from a strong-buy rating to a market perform rating in a research report on Wednesday, October 18th. Two analysts have rated the stock with a sell rating, six have issued a hold rating and seventeen have assigned a buy rating to the company. The company currently has an average rating of Buy and a consensus target price of $89.95.
HCA Holdings (NYSE HCA) traded down $1.66 on Thursday, hitting $76.05. 3,323,200 shares of the stock were exchanged, compared to its average volume of 2,273,521. HCA Holdings has a one year low of $69.18 and a one year high of $91.03. The company has a current ratio of 1.68, a quick ratio of 1.41 and a debt-to-equity ratio of -6.46. The firm has a market cap of $27,513.42, a P/E ratio of 11.79, a P/E/G ratio of 1.14 and a beta of 0.50.
HCA Holdings (NYSE:HCA) last posted its earnings results on Tuesday, October 31st. The company reported $1.21 EPS for the quarter, hitting the consensus estimate of $1.21. HCA Holdings had a net margin of 6.13% and a negative return on equity of 47.16%. The business had revenue of $10.70 billion for the quarter, compared to the consensus estimate of $10.70 billion. During the same period last year, the company earned $1.45 EPS. The firm’s revenue was up 4.1% compared to the same quarter last year. equities analysts predict that HCA Holdings will post 6.55 earnings per share for the current fiscal year.
HCA Holdings announced that its Board of Directors has authorized a stock buyback plan on Tuesday, October 31st that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s leadership believes its stock is undervalued.
In related news, SVP Victor L. Campbell sold 8,000 shares of the company’s stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $78.00, for a total value of $624,000.00. Following the transaction, the senior vice president now directly owns 127,275 shares in the company, valued at $9,927,450. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction that occurred on Tuesday, October 17th. The stock was sold at an average price of $78.00, for a total transaction of $167,700.00. Following the completion of the transaction, the insider now owns 12,476 shares in the company, valued at $973,128. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 12,300 shares of company stock worth $963,421. Company insiders own 2.90% of the company’s stock.
A number of hedge funds and other institutional investors have recently modified their holdings of HCA. Northwestern Mutual Wealth Management Co. grew its position in HCA Holdings by 14.0% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock valued at $101,000 after acquiring an additional 143 shares during the last quarter. Bronfman E.L. Rothschild L.P. grew its position in HCA Holdings by 35.1% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock valued at $107,000 after acquiring an additional 320 shares during the last quarter. Atlantic Trust LLC bought a new position in HCA Holdings during the second quarter valued at approximately $118,000. Lee Financial Co bought a new position in HCA Holdings during the second quarter valued at approximately $125,000. Finally, Acrospire Investment Management LLC grew its position in HCA Holdings by 14.3% during the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock valued at $140,000 after acquiring an additional 200 shares during the last quarter. Institutional investors and hedge funds own 75.93% of the company’s stock.
HCA Holdings Company Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with our FREE daily email newsletter.